Vikram Raje, DO
Advanced Heart Failure and Transplant Cardiology · Gainesville, GANPI 1649563255
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.4%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Cvrx, Inc. at 29.4% of the total.
Across 345 payments — averaging $54.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$6K
- Medtronic$4K
- Abiomed$2K
- Merck$946
- Abbott$807
- Boston Scientific$771
- plus $5K from 28 others
What the payments were for
- Grants$3,25017%
- Travel & lodging$5,08327%
- Food & beverage$10,20554%
- Education$2361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 36 | $5,521 |
| Medtronic(2 entities) | 6 | $3,576 |
| Abiomed | 11 | $2,315 |
| Merck | 45 | $946 |
| Abbott | 16 | $807 |
| Boston Scientific | 18 | $771 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 30 | $709 |
| Actelion Pharmaceuticals US, Inc. | 27 | $524 |
| Novo Nordisk | 20 | $385 |
| Impulse Dynamics (USA) Inc. | 9 | $326 |
| E.r. Squibb & Sons, L.L.C. | 14 | $313 |
| Novartis | 16 | $295 |
| Pfizer | 13 | $252 |
| AstraZeneca | 14 | $238 |
| Johnson & Johnson | 12 | $177 |
| Boehringer Ingelheim | 10 | $171 |
| Bard Peripheral Vascular, Inc. | 2 | $157 |
| Bridgebio Pharma, Inc. | 4 | $152 |
| Inari Medical, Inc. | 2 | $142 |
| Lexicon Pharmaceuticals, Inc. | 7 | $136 |
| Atricure, Inc. | 2 | $134 |
| Edwards Lifesciences | 1 | $126 |
| Bayer | 4 | $103 |
| Alnylam Pharmaceuticals Inc. | 5 | $101 |
| Amgen | 4 | $82 |
| Daiichi Sankyo Inc. | 4 | $74 |
| Scpharmaceuticals Inc. | 4 | $59 |
| Kestra Medical Technology Services, Inc. | 3 | $56 |
| Shockwave Medical, Inc | 1 | $30 |
| Baxter Healthcare | 1 | $23 |
| Angiodynamics, Inc. | 1 | $20 |
| United Therapeutics Corporation | 1 | $19 |
| Livanova USA, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$4,645
- Resolute$3,250
- Impella$1,909
- CARDIOMEMS$260
- Integrity$210
- OPTIMIZER$204
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$153
- GENERAL VASCULAR ACCESS$130
- OPTICROSS$127
- Edwards SAPIEN 3 Transcatheter Heart Valve$126
- CAMZYOS$120
- FLOWTRIEVER CATHETER, S$116
- CT THROMBECTOMY SYSTEM KIT$116
- SYNERGY ABLATION SYSTEM$109
- GENERAL - THERAPIES$107
- Attruby$105
How this compares
$18,774 in reported general payments places this provider in the 60th percentile of 40 advanced heart failure and transplant cardiology providers in Georgia.
See all advanced heart failure and transplant cardiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 770 | $892,989 |
| FarxigaDapagliflozin Propanediol | 307 | $323,205 |
| OpsumitMacitentan | 19 | $295,397 |
| JardianceEmpagliflozin | 217 | $259,918 |
| EliquisApixaban | 265 | $249,086 |
| CamzyosMavacamten | 32 | $244,124 |
| VerquvoVericiguat | 81 | $78,638 |
| XareltoRivaroxaban | 58 | $69,619 |
| OzempicSemaglutide | 48 | $61,524 |
| BrilintaTicagrelor | 78 | $55,697 |
| Repatha SureclickEvolocumab | 58 | $41,257 |
| Ambrisentan | 11 | $35,442 |
| MounjaroTirzepatide | 23 | $28,812 |
| Sildenafil Citrate | 33 | $13,852 |
| CorlanorIvabradine Hcl | 14 | $12,913 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $295 | $892,989770 claims |
| AstraZenecaFarxiga, Brilinta | $238 | $378,901385 claims |
| Actelion Pharmaceuticals US, Inc.Opsumit | $524 | $295,39719 claims |
| Boehringer IngelheimJardiance | $171 | $259,918217 claims |
| PfizerEliquis | $252 | $249,086265 claims |
| E.r. Squibb & Sons, L.L.C.Camzyos | $313 | $244,12432 claims |
| MerckVerquvo | $946 | $78,63881 claims |
| Johnson & JohnsonXarelto | $177 | $69,61958 claims |
| Novo NordiskOzempic | $385 | $61,52448 claims |
| Lilly USA, LLCMounjaro | $17 | $28,81223 claims |
| AmgenCorlanor | $82 | $12,91314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 40 advanced heart failure and transplant cardiology providers in Georgia.
Other advanced heart failure and transplant cardiology in Gainesville
- Ugochukwu EgolumGainesville$235K
- Alanna MorrisGainesville$85K
- Evan HinerGainesville$48K
- Alison BaileyGainesville$28K
- Giancarlo AcostaGainesville$10K
- Nitya ChandraGainesville$4K
- Lawrence CharlesGainesville$4K
- Andrew DarlingtonFayetteville$1M
- Catherine MartiAthens$343K
- Darshak KariaAugusta$296K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.